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methylation data and mediation by cell
composition effects
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Abstract
Background: Recent interest in reference-free deconvolution of DNA methylation data has led to several
supervised methods, but these methods do not easily permit the interpretation of underlying cell types.
Results: We propose a simple method for reference-free deconvolution that provides both proportions of
putative cell types defined by their underlying methylomes, the number of these constituent cell types, as
well as a method for evaluating the extent to which the underlying methylomes reflect specific types of cells.
We demonstrate these methods in an analysis of 23 Infinium data sets from 13 distinct data collection efforts;
these empirical evaluations show that our algorithm can reasonably estimate the number of constituent types,
return cell proportion estimates that demonstrate anticipated associations with underlying phenotypic data;
and methylomes that reflect the underlying biology of constituent cell types.
Conclusions: Our methodology permits an explicit quantitation of the mediation of phenotypic associations
with DNA methylation by cell composition effects. Although more work is needed to investigate functional
information related to estimated methylomes, our proposed method provides a novel and useful foundation
for conducting DNA methylation studies on heterogeneous tissues lacking reference data.
Keywords: Deconvolution, DNA methylation, Epigenetics, Non-negative matrix factorization
Background
In the last decade, there has been an increasing interest
in epigenome-wide association studies (EWAS), which
aim to investigate associations between DNA methyla-
tion and health or exposure phenotypes across the gen-
ome. Numerous publications have reported associations
between DNA methylation profiled in a single tissue and
disease states or exposure phenotypes. Most of these
studies have used whole blood [1] or cord blood [2–4],
but some have used other media such as buccal swabs
[5], adipose tissue [6, 7], and placenta [8–11].
However, most tissues are complex mosaic of cells
derived from at least two and sometimes three different
germ layers; endoderm, mesoderm and ectoderm that
give rise to both epithelial and stromal compartments.
Just the epithelial component of an organ can be
composed of many cell types; for example we found
that breast epithelium is composed of at least 10–12
cell types [12] with potentially distinct DNA methyla-
tion profiles [13]. Added to this complexity are the
cells in the stromal component with distinct functions,
including vascular and lymphoid endothelial cells and
pericytes, immune cells such as macrophages, leuko-
cytes and lymphocytes, stromal fibroblasts, myofibro-
blasts, myoepithelial cells, as well as adipose cells,
endocrine cells, nerve cells and other cellular and tis-
sue elements that have different but systematically
varying developmental origins. The complexity of the
epigenome in normal tissues has been described in a
recent analysis of 111 reference human epigenomes of
human tissues [14]. Thus, because normal tissue devel-
opment, individual cellular differentiation and cellular
lineage determination are regulated by epigenetic
mechanisms, which include chromatin alterations as
well as DNA methylation [15–18], many phenotypic
associations with DNA methylation may be explained
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in whole or in part by systematic associations with the
distribution of underlying cell types. This has been
demonstrated statistically in numerous papers [19–22]
and in one notable recently published manuscript
which identified and confirmed the specific cell sub-
type responsible for the highly replicated relationship
between tobacco smoking exposure and DNA methy-
lation of the GPR15 locus [23]. This phenomenon has
led to an interest in methods for adjusting EWAS
studies for cell-type heterogeneity. In referenced-based
deconvolution methods, the distribution of cell types
is obtained by projecting whole-tissue DNA methyla-
tion data onto linear spaces spanned by cell-type-
specific methylation profiles for a specific set of CpGs
that distinguish the cell types, so-called differentially
methylated positions (DMPs) [19]; these methods re-
quire the existence of a reference set consisting of the
cell-type specific methylation profiles, such as those
that exist for blood [19, 24, 25]. However, no such ref-
erence sets exist for solid tissues of interest, such as
adipose and placenta, or even tumors, thus motivating
reference-free methods [13, 26, 27] that seek to adjust
DNA methylation associations for cell-type distribution.
Numerous cell-type deconvolution methods are cur-
rently available, many of them based on mRNA or protein
expression [28]; all of them are essentially either reference-
based, i.e. supervised by the pre-selection of loci known
to differentiate cell types, or else reference-free, i.e. es-
sentially unsupervised. While reference-based decon-
volution methods allow for direct inference of the
relationship between phenotypic variation and altered
cell composition of characterized cell subtypes, reference-
free approaches can provide only limited, if any, informa-
tion on the types of cells contributing to the phenotypic
association. In this article we propose a simple method for
reference-free deconvolution that addresses this challenge
and that provides both interpretable outputs – propor-
tions of putative cell types defined by their underlying
DNA methylation profiles – as well as a means for evalu-
ating the extent to which the underlying profiles reflect
specific types of cells.
Our fundamental approach is as follows: we assume
an m × n matrix Y representing DNA methylation data
collected for n subjects or specimens, each measured on
an array of m CpG loci, and that the measured values
are constrained to the unit interval [0, 1], each roughly
representing the fraction of methylated cytosine mole-
cules in the given sample at a specific genomic position.
This conforms to the typical average beta output of
popular platforms such as the Infinium arrays by Illumina,
Inc. (San Diego, CA), i.e. the older HumanMethylation27
(27K) platform, which interrogates 27,578 CpG loci, and
the newer HumanMethylation450 (450K) platform, which
interrogates 485,412 CpG loci; however, it also conforms
to the results of sequencing-based platforms such as
whole genome bisulfite sequencing (WGBS). In reference-
based methods, the following relation is assumed to hold:
Y =MΩT, where M is a known m ×K matrix representing
m CpG-specific methylation states for K cell types and Ω
is an n ×K matrix representing subject-specific cell-type
distributions (each row representing the cell-type pro-
portions for a given subject, i.e. the entries of Ω lie
within [0, 1] and the rows of Ω sum to values less than
one). Reference-free methods attempt to circumvent
lack of knowledge about M either by using a two-stage
regression analysis (e.g. the Houseman approach [27])
or else fitting a high-dimensional mixed-effects model
and equating the resulting random coefficients with
cell-mixture effects (i.e. the Zou approach [26]); both
methods rely on a predetermined model positing asso-
ciations between DNA methylation Y and phenotypes
X. For example, the Houseman method posits the
model Y =AXT + R, where X is an n × d design matrix
of phenotype variables and potential confounders; the
m × d regression coefficient matrix A and the m × n
error matrix R are both assumed to have further linear
structure involving M, and the common variation be-
tween A and R is assumed to represent systematic asso-
ciation with cell type distribution. However, results of
this approach are somewhat influenced by the choice of
the dimension of the linear subspace of [A, R] repre-
senting the common variance induced by M [20]; con-
sequently there has been recent concern that the
method may over-adjust for cell distribution. A similar
problem exists with the Zou approach, which models
the phenotype as a linear function of DNA methylation,
and in which the choice of a tuning parameter can in-
fluence the extent to which phenotypic associations are
putatively explained by heterogeneity in underlying cell
types. Here, we propose that a variant of non-negative
matrix factorization be used to decompose Y as Y =
MΩT, where the entries of the unknown matrices M
and Ω are constrained to lie in the unit interval and
the rows of Ω are constrained to sum to a value less
than or equal to one. This approach is similar to existing
approaches for estimating the proportion of normal tissue
cells in a tumor sample or otherwise deconvolving mix-
tures of cells [29–33]. Additionally, this factorization con-
forms to the biological assumption that DNA methylation
measurements Y, regardless of associated metadata X,
ultimately arise as linear combinations of constituent
methylomes, as we have previously argued [20]. However,
such constrained factorizations can be computationally in-
tensive, and it is still necessary to specify the number K of
assumed cell types, so in Additional file 1: Section S1 we
propose a fast approximation that facilitates resampling,
which is the basis of our method for determining K, de-
scribed in Additional file 1: Section S2. Note that K = 1
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corresponds to the case where there are no relevant con-
stituent cell types, which should be true for relatively pure
media. If associations remain between Ω and X, i.e. if the
associations between X and Y factor through the decom-
position Y =MΩT, then these associations are potentially
explained by systematic changes in cell composition. Evi-
dence for mediation of associations by cell type is substan-
tially strengthened if the methylomes represented by M
map to biological processes that correspond to distinct pop-
ulations of cells. To that end, we propose a simple compan-
ion analytical procedure for the interpretation of the
methylomes represented byM. Denote each row ofM (cor-
responding to one CpG) as the K × 1 vector μj, j ∈ {1,…,m}.
CpG loci that most differentiate the K putative cell types
will tend to have distinct values within μj; thus high values
of the row-variance sj
2 = var{μj1,…, μjK} should correspond
to CpGs that are most relevant to the biological distinctions
among the K cell types, and this can be tested with auxiliary
annotation data. Figure 1 illustrates our approach.
We demonstrate these methods in analyses of 23 gen-
ome-scale DNA methylation data sets from 13 distinct
data collection efforts, including four blood data sets,
several breast tumor data sets (including data from The
Cancer Genome Atlas, TCGA), vascular and liver tissues,
sperm, and four separate media collected on the same
population, Bangladeshi neonates, including placenta. In
addition, we leverage data derived from The Roadmap
Epigenomics Project, demonstrating their utility in ad-
dressing the biological relevance of fitted methylomesM.
Results
To test our proposed approach, we analyzed 23 DNA
methylation datasets from 13 distinct studies, each set of
DNA methylation measurements obtained via the Infinium
27K or 450K platform. Four blood data sets [3, 22, 34, 35]
were included as positive controls (given the existing refer-
ence data and known heterogeneity), each collected in the
context of an epidemiologic study, and each assumed to ex-
hibit heterogeneity in cell type as previously described [3,
19, 22]. Sperm [36] and isolated vascular tissues [37] were
included as negative controls, presumed to represent rela-
tive homogeneity in terms of constituent cell types. Note
that four datasets arose from one study on arsenic expos-
ure in Bangladeshi neonates [3, 9], in which four separate
tissues were obtained from the same individuals. Also in-
cluded were arterial tissue [38], liver tissue [39], and data
from cancer data sets [40–43], including breast tissues
from TCGA [44]. Table 1 lists the data sets, their sources
and their short descriptions. Additional file 1: Figure S3.1
shows the results of hierarchical clustering applied to
26,476 CpG sites common across the datasets (Manhattan
distances based on mean methylation for the data set, clus-
tering based on Ward’s method implemented asWard.D in
R version 3.2.2). Additional file 1: Figure S3.2 summarizes
the number of CpGs analyzed for each data set, by fraction
of samples observed for each CpG. Note the strong cluster-
ing of data sets by type of media. The ordering of data sets
in Table 1 and many subsequent figures are based on the
clusters shown in Additional file 1: Figure S3.1.
Fig. 1 Overview of proposed Methods. If associations between DNA methylation data Y and phenotypic metadata X factor through the
decomposition Y =MΩT, and the data in M serve to distinguish cell types by their associations with relevant annotation data, then
associations between X and Y are explained in whole or in part by differences in the distribution of constituent cell types. Numbers
indicate steps in analysis: (1) deconvolution; (2) determining discriminating loci; (3) gene-set analysis; (4) analysis of associations with phenotype
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Table 1 Summary of Datasets
Code Tissue Source Ref Platform Source description Number Covariate model
g[nt] gastric tissue: tumor + normal GEO:
GSE30601
[42] 27K 203 gastric tumors and 94 matched gastric non-malignant samples. 297 Tumor[normal|tumor]
g[n] gastric tissue: normal 94 –
g[t] gastric tissue: tumor 203 –
br-1[t] breast: tumor GEO:
GSE20712
[43] 27K 119 breast tumor samples with histological information.
Removed 29 samples with ambiguous or missing histology.
119 Histology[basal|HER2|LumA|LumB] +
Age[young|old] + Size[small|large]
br-2[t] breast: tumor GEO:
GSE31979
[40] 27K 103 primary invasive breast tumors. 90 Histology[basal|ER-|ER+|HER2|LumA|LumB] + Age
br-3[t] breast: tumor GEO:
GSE32393
[41] 27K Breast tumor samples: 91 invasive ductal, 13 invasive lobular,
10 mucinous or medullary; 76 were ER+.
114 ER[ER-|ER+] + Histology[duct|lob|muc or med] +
Age
bl-ov peripheral blood GEO:
GSE19711
[35] 27K Whole blood from 131 ovarian cancer cases (drawn pre-treatment)
and 274 controls.
402 Case[control|ovarian cancer case] + Age
bl-hn peripheral blood GEO:
GSE30229*
[34] 27K Peripheral blood from 92 head and neck squamous cell carcinoma
(HNSCC) patients and 92 controls. Removed 2 outlier cases.
182 Case[control|HNSCC case] + Age
BL-ra peripheral blood GEO:
GSE42861
[22] 450K Peripheral blood from 354 rheumatoid arthritis patients and
335 controls.
689 Case[control|arthritis case]
BL-as cord blood (not public) [3] 450K* Cord blood from 45 Bangladeshi neonates, with corresponding
drinking water arsenic concentrations.
45 Log-arsenic + Sex[female|male]
SP sperm GEO:
GSE47627
[36] 450K 26 normal sperm samples. 26 Fraction[swim down|swim up|whole
1h|whole 2h]
BV+LV endothelial tissue 16 Source[BV|LV]
BV endothelial tissue: blood vessel GEO:
GSE34487
[37] 450K 16 vascular samples: 6 primary blood vessel endothelial cell samples
and 10 primary lymphatic endothelial cell samples.
6 –
LV endothelial tissue:
lymphatic vessel
10 –
UV-as umbilical vein endothelial tissue (not public) [9] 450K* Umbilical vein endothelial tissues from 51 Bangladeshi neonates,
with corresponding drinking water arsenic concentrations.
51 Log-arsenic + Sex[female|male]
AR-as placental artery (not public) [9] 450K* Placental arteries from 46 Bangladeshi neonates, with corresponding
drinking water arsenic concentrations.
46 Log-arsenic + Sex[female|male]
AR[np] arterial tissue:
atherosclerotic + normal
GEO:
GSE46394
[38] 450K 15 normal aortic tissues, 15 atherosclerotic aortic lesions, 19 carotid
atherosclerotic samples.
49 Source[normal|ath|carotid ath] +
Sex[female|male] + Age
AR[n] arterial tissue: normal aorta 15 −
PL-as placenta (not public) [9] 450K* Placentas from 45 Bangladeshi neonates, with corresponding
drinking water arsenic concentrations.
45 Log-arsenic + Sex[female|male]
L[np] liver tissue: cirrhotic + normal GEO:
GSE60753
[39] 450K 34 normal liver tissues, 21 cirrhotic tissues (due to alcoholism),
45 cirrhotic tissues [due to chronic hepatitis B (HBV) or C (HCV) viral
100 Source[normal|CirrEtOH|CirrV]
L[n] liver tissue: normal 34 –
BR-tcga[n] breast: normal TCGA
(11/2014)
[44] 450K* 96 normal breast tissues (matched to tumor) from The Cancer
Genome Atlas, downloaded Nov. 2014
96 Age + Race[white|other]
BR-tcga[t] breast: tumor 450K* 725 breast tumors from The Cancer Genome Atlas,
downloaded Nov. 2014
725 Age + Race[white|other] + Staging[II+|III+|IV/X|?] +
ER[ER+|ER-] + HER2[HER2+|HER2-|HER2?]
*Processed from idat files using FunNorm algorithm (Bioconductor library minfi). See Methods for details
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Estimated numbers of cell types
Using the method described in Additional file 1: Section
S2 with 25 iterations, for each data set we found the de-
composition Y =MΩT, for values of K varying from 2 to
either Kmax = 10 or the maximum possible given the
sample size (Kmax = 8 for BV+LV, 2 for BV and LV, 7 for
AR[n]). We then used our bootstrap approach (Additional
file 1: Section S3) for determining the number K^ of classes
for each data set, displayed in Fig. 2a, which demonstrates
heterogeneity in the number of classes K^ estimated. K^≥3
for blood data sets (K^ ¼ 3 for the cord blood data set BL-
as, larger for the other three peripheral blood datasets).
For breast tissues (both tumor and normal) K^ was typic-
ally large. K^≥3 for the artery and liver data sets having
three distinct sources each (AR[np] and L[np]). K^ ¼ 1 for
the pure blood and lymphatic vessel data sets (BV and
LV); K^ ¼ 2 for other vessel data sets consisting of normal
tissue (AR[n], AR-as, BV+LV, UV-as), for the normal liver
data set L[n], for sperm (SP) and for placenta (PL-as).
We remark that K^ was typically lower for datasets that
were more likely to be comprised of homogeneous tis-
sues. We also remark that our proposed method of
selecting K^ is based on minimizing a bootstrapped de-
viance statistic, and that the variation of this statistic
across values of K can be informative. For example,
with the BL-ra dataset, the deviance dropped precipi-
tously from K = 1 to K = 3, while for the sperm data set
the deviance remained flat from K = 1 to K = 6 before
rapidly increasing (Fig. 2b).
Associations with phenotypic metadata
To examine the associations between Ω and various
metadata associated with the subjects/specimens in the
corresponding study, we fit a quasi-binomial model for
each row of Ω; Table 1 provides the covariate model X
used for each data set. As described below and in detail in
Additional file 1: Section S4, to circumvent dependence of
results on the choice of K, we examined associations over
the range K ∈ {1,…,Kmax}, using a permutation test (1000
permutations) for inference on each covariate. Table 2
provides a summary of permutation test results. As shown
in Table 2, cell mixture proportions Ω were typically sig-
nificantly associated with major phenotypes of interest
and occasionally with age (e.g. bl-hn and BR-tcga[t]); the
exception was the sperm dataset, for whichΩ was not sig-
nificantly associated with fraction. Note in particular that
for breast tumors, ER status variables (or histology vari-
ables incorporating ER status) were significantly associ-
ated with Ω. Sex was typically not significantly associated
with Ω. As shown in Fig. 2, the associations between Ω
and phenotype could be quite striking (e.g. rheumatoid
arthritis status) or completely lacking (e.g. sperm fraction).
Figure 3a shows clustering heatmap of Ω (K ¼ K^ ¼ 10)
for BL-ra, one of the positive control blood data sets, with
annotation track showing the associated phenotype
rheumatoid arthritis case/control status. Figure 3b shows
a similar clustering heatmap for the negative control SP
(sperm, K ¼ K^ ¼ 2), along with the associated phenotype,
specimen fraction. Other clustering heatmaps are pro-
vided supplementary files.
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Fig. 2 Selection of Number of Classes K. a Estimated number K^ of classes for each data set. b Bootstrapped deviance profiles for four selected
data sets, along with mean deviance, median deviance, and quartiles for each value of K
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We also considered the effect of Ω on CpG-specific
associations of DNA methylation with X. As described
below and in detail in Additional file 1: Section S5, we
computed regression coefficients for logit-methylation
(i.e. M-values) upon [X,Ω] for K ∈ {1,…, Kmax} (for K = 1
the covariate model was simply X); for Ω and for each
covariate, we then used the resulting nominal p-values
to estimate the proportion π0 of null associations. For
demographic variables (age, sex, race), Additional file 1:
Figure S5.1 illustrates the value of π0 for the overall as-
sociation of Ω with DNA methylation (K ¼ K  ¼ max
2; K^
 
). For demographic variables, Additional file 1:
Figure S5.2 provides a comparison of π0 from the K = 1
model with π0 from the K = K* model. Figure 4 displays
a similar comparison for other variables. These figures
demonstrate that adjustment by Ω very often resulted in
higher values of π0, the estimated proportion of null as-
sociations. Exceptions were normal vs. cirrhotic liver
(Fig. 4, Additional file 1: Table S5.2), age in bl-hn and
sex in AR[np] and AR-as (Additional file 1: Figure S5.2,
Table S5.1); for these variables, adjustment by Ω reduced
π0. These cases may represent instances where Ω clari-
fied single-locus associations; for example, adjusting for
cellular heterogeneity in liver (e.g. hepatocytes vs. fibrous
tissue) may clarify the detailed molecular profile of the
two distinct types of liver pathologies (alcohol vs. viral
Table 2 Inference with Phenotypic Metadata
Data set Permutaton P-values
g[nt] Tumor < 0.001
br-1[t] Histology < 0.001; Age = 0.059; Size = 0.016
br-2[t] Histology < 0.001; Age = 0.06
br-3[t] ER < 0.001; Histology = 0.295; Age = 0.008; BSC = 0.297
bl-ov Case < 0.001; Age = 0.999
bl-hn Case < 0.001; Age < 0.001
BL-ra Case < 0.001
BL-as Log-arsenic < 0.001; Sex = 0.263
SP Fraction = 0.994
BV+LV Source = 0.013
UV-as Log-arsenic = 0.515; Sex = 0.962
AR-as Log-arsenic = 0.285; Sex = 0.505
AR[np] Source < 0.001; Sex = 0.043; Age = 0.377
PL-as Log-arsenic = 0.006; Sex = 0.451
L[np] Source < 0.001
BR-tcga[n] Age = 0.089; Race = 0.153
BR-tcga[t] Age < 0.001; Race < 0.001; Staging = 0.013; ER < 0.001;
HER2 < 0.001
a – Blood from Rheumatoid Arthritis Cases and Controls b – Healthy Sperm
100%
50%
0%
Cell Proportion
Fig. 3 Cell Proportion Matrices. Clustering heatmaps of cell proportion matrix Ω for two data sets; purple intensity indicates cell proportion. a
Blood from rheumatoid arthritis cases and controls (BL-ra, K ¼ K^ ¼ 10); clustering heatmap obtained from untransformed coefficients and using
Ward’s method of clustering (“ward.D” in R hclust function). b Sperm (SP, K ¼ K^ ¼ 2)
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cirrhosis). On the other hand, the proportion of null as-
sociations with Ω was typically low: except for the
homogeneous tissue datasets SP and BL+LV, π0 was less
than 0.2; of the others, except for the arsenic-exposure
data sets UV-as, AR-as, and PL-as, π0 was extremely
close to zero.
Interpretation of putative cell types
We examined the biological relevance of resulting matri-
ces M in several different ways. First, for each data set,
we computed row-variances sj
2 (as described above) both
for K = 2 and for K ¼ max 2; K^  . For each of these
two values of K, we classified each CpG j ∈ {1,…,m} by
whether its row-variance sj
2 lay above the 75th percentile
q0.75(s
2), reasoning that methylation of these loci vary
more across cell types, and thus these CpGs could be
important cell type discriminators. Next, we obtained a
list of DMPs for differentiating distinct major types of
leukocytes (Blood DMPs), and another list of CpGs
mapped to genes considered Polycomb Group proteins
(PcG loci), the construction of both lists described in detail
in Additional file 1: Section S6. For each data set we
computed the odds ratio for the association of high
row-variance (defined as sj
2 > q0.75(s
2)) with DMP set
membership (Blood DMPs or PcG loci), using Fisher’s
exact test to compute the corresponding p-values.
Odds ratios are depicted in Fig. 5, with log10 p-values
given in Additional file 1: Table S6.1. Blood DMP status
showed the highest associations in blood data sets, al-
though somewhat high associations were also observed in
L[np] and AR[np] (data sets having tissues with potentially
inflammatory components to pathology). Data sets with
tumors (BR-tcga[t], br-1[t], br-2[t], br-3[t], g[nt], and g[t])
showed high association of PcG loci with cell-type distin-
guishing CpGs, but so did the data set with normal gastric
tissue, g[n]. As shown in Additional file 1: Figure S6.1, the
Bilenky DMPs, which were based on breast tissue, showed
the highest association with cell-type discriminating CpGs
in the data sets with breast tissue, although associations
were also high in L[np], AR[n], and AR[np]. As shown in
Additional file 1: Figure S6.2, the REMC DMPs, based on
comparison of ectodermal/mesodermal/endodermal dis-
tinctions among embryonic stem cells, showed relatively
weak (or negative) associations with cell-type distinguish-
ing CpGs for all datasets. Figure 5 also suggests that odds
ratios were slightly, though consistently, higher for K = 2
than for K ¼ max 2; K^ , this may indicate that DMPs
and polycomb targets are distinguished principally by two
distinct types of cells, and that additional cell types add
noise with respect to these specific comparisons.
We also developed a novel approach based on WGBS
data from the Roadmap Epigenomics Project for 24 pri-
mary tissues. For each sample, we obtained the 470,909
CpGs overlapping with CpGs from either Infinium array
(and having fewer than 3 missing values), clustering the
tissue samples based on the 15,000 most variable of
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Fig. 4 Comparison of Null Associations. Comparison of π0 (proportion of null association CpGs) from the K = 1 model with π0 from the K = K* model;
only non-demographic variables are shown
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these CpGs (Manhattan distance metric with Ward’s
method of clustering). The resulting dendrogram, shown
in Additional file 1: Figure S7.1, demonstrates substan-
tial clustering along general tissue type. We also applied
our deconvolution algorithm to these 24 tissue samples
(K = 6), with results shown in Additional file 1: Figure
S7.2; note that the deconvolution of these tissues resulted
in constituent cell types that roughly aligned with antici-
pated anatomical associations, e.g. tissues with substantial
smooth or skeletal muscle mapped to one cell type,
tissues with a substantial lymphoid/immune component
mapped to another, and central nervous tissues map to
yet another. We reasoned that similar tissue types would
differ principally in the proportion of underlying normal
constituent cell types, and thus provide information on
cell-type heterogeneity underlying other tissues of similar
type. Consequently, we selected the tissue pairs corre-
sponding to the 25 smallest Manhattan distances (as
calculated for the clustering in Additional file 1: Figure
S7.1), with pairs illustrated as network edges in Additional
file 1: Figure S7.3. Due to small numbers of DMPs (10 or
fewer) we excluded two pairs; for each of the remaining
23 pairs, we identified, among the 15,000 CpGs most vari-
able across all 24 tissue types, those CpGs that differed in
methylation fraction by greater than 0.70 between the two
samples; we considered these CpGs to be Infinium-
specific DMPs for tissue-specific heterogeneity. Using
these 23 sets of DMPs, we conducted a gene-set analysis
as described in the previous paragraph. The clustering
heatmap in Fig. 6 presents the odds ratios for the 450K
data with K  ¼ max 2; K^ ; the heatmap in Additional file
1: Figure S6.4 presents the odds ratios for the 27K data
with K ¼ max 2; K^ , and the odds ratios for K = 2 are
given in Additional file 1: Figures S7.5 and S7.6. Corre-
sponding p-values are given in Additional file 1: Tables
S7.1, S7.2 and S7.3. Note that we excluded additional
pairs from the 27K array analysis due to small DMP
overlap with the 27K array. As shown in Fig. 6, posi-
tions that distinguished immune-related tissues (CD34+
hematopoietic stem cells vs. thymus or spleen) were
highly associated with CpGs distinguishing cell types in
the two 450K blood data sets, as well as in the mixed liver
tissue dataset L[np] and the mixed arterial dataset AR[np],
consistent with the findings demonstrated in Fig. 5a. In
the arterial data sets AR[n] and AR[np], the normal breast
data set BR-tcga[n] and to some extent the normal mixed
vessel data set BV+LV, high associations were found for
CpGs that distinguished smooth muscle content (aorta vs.
psoas muscle, heart atrium vs. ventricle, heart atrium vs.
esophagus). Interestingly, AR[n], AR[np], and BR-tcga[n]
displayed associations with CpGs distinguishing lung and
esophagus, potentially an epithelial cell comparison (al-
though potentially also representing a distinction in
smooth muscle content). All other positive associations
were relatively weak. Strong negative associations with
CpGs that distinguished right atrium from left ventricle
were observed for L[n], SP, UV-as, and AR-as, although
these results may be driven by small numbers of CpGs
(see p-values in Additional file 1: Table S7.2). Patterns
were similar for K = 2 (Additional file 1: Figure S7.5). Pat-
terns were similar in 27K blood data sets; additionally, the
normal gastric data set g[n] displayed high association
with DMPs distinguishing Roadmap stomach tissues
(Additional file 1: Figure S7.4). Interestingly, L[n] was
a – Blood PMDs b – Polycomb Group Protein Loci
g[n]
g[nt]
g[t]
br-3[t]
br-1[t]
br-2[t]
bl-ov
bl-hn
BL-ra
BL-as
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BV
BV+LV
LV
UV-as
AR-as
AR[np]
AR[n]
PL-as
L[np]
L[n]
BR-tcga[n]
BR-tcga[t] K=K*
K=2
OR
1 1.5 2 3 4 5 7.5 10 15 20 30
g[n]
g[nt]
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br-3[t]
br-1[t]
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BL-as
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BV
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AR[np]
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Fig. 5 Gene-Set Analysis (DMPs and PcG Targets). Gene-set odds ratios, showing the association of gene set membership with the set of CpGs
whose values are highly variable across fitted methylomes (sj
2 > q0.75(s
2)). a Blood DMRs. b CpGs mapped to polycomb group protein genes
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the only dataset displaying mostly negative (though
weak) associations.
Additional analyses
As described fully in Additional file 1: Section S8, we
compared our proposed reference-free method with ref-
erence-based methods applied to the BL-ra and BL-as
data sets, addressing (1) the extent to which the
reference-based and reference-free approaches were
consistent in their results; and (2) the extent to which
our unsupervised approach may provide additional in-
formation on immune response and inflammation (as
represented by distributions of leukocytes including
their various activation states) beyond associations with
simply the major types of leukocytes. Although un-
supervised methods failed to return the exact biologic-
ally relevant cell types, they returned putative cell types
that were related to the true types by a linear mixing
matrix, and the phenotypic associations with true cell
types were extremely consistent with associations pro-
duced in the reference free analysis, after accounting
for the linear transformation (Additional file 1: Figures
S8.3 through S8.6). Additionally, correlation of methy-
lome M (from our reference-free method) with DMPs
based on Roadmap WGBS data was substantially reduced
after accounting for methylation differences among major
types of leukocytes (Additional file 1: Figure S8.7 through
Figure S8.10), suggesting that both reference-free and
reference-based methylomes M contain similar cell-type
information. Gene-set analyses demonstrated that both
our approach and the reference-based method were simi-
lar in the immune sets they identified as functionally rele-
vant to rheumatoid arthritis (Additional file 1: Figure
S8.11), while our approach (with K = 7) identified several
immune processes potentially functionally relevant to
arsenic exposure but missed by the reference-based ap-
proach (Additional file 1: Figure S8.12).
We compared our method to Surrogate Variable
Analysis (SVA [45]), a popular method currently
used for reference-free analysis. With K = 7, SVA
found many of the same functionally relevant im-
mune processes, but they were evident in the re-
sidual associations, i.e. the CpG-specific associations
obtained after adjusting for the SVA analogue of Ω,
not in the surrogate variables that presumably repre-
sent cell mixture. However, after raising K to 33, the
value estimated by SVA, results were more similar to
those obtained by our method. This suggests that
SVA produces results that are similar to our method,
but using greater degrees-of-freedom.
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Fig. 6 Gene-Set Analysis (Roadmap Epigenomics WGBS). Gene-set odds ratios for 450K data sets, showing association of sets of DMPs distinguishing
various Roadmap Epigenomics WGBS specimens with the set of CpGs whose values are highly variable across fitted methylomes (sj
2 > q0.75(s
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Clustering heatmap obtained from log-odds-ratios and using Ward’s method of clustering (“ward.D” in R hclust function)
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Finally, as described in Additional file 1: Section S9,
notable distinctions between normal and pathological
tissues were revealed in an analysis of cell proportions Ω
obtained using the Roadmap-derived methylomes as a
reference (Additional file 1: Figures S9.1 through S9.3).
In particular, gastric tumors differed from normal gastric
tissues in having greater immunological/inflammation
content but lesser gastrointestinal content, atheroscle-
rotic carotid (and to some extent atherosclerotic aorta)
differed from normal aorta in having greater immuno-
logical/inflammation content but lesser muscular content,
and cirrhotic tissues differed from normal liver tissues in
having greater immunological/inflammation content but
lesser gastrointestinal content (with the pattern more
striking for cirrhotic tissues related to viral infection than
for cirrhotic tissues related to alcohol abuse).
Simulations
In Additional file 1: Section S10 we describe simulations
that illustrate the behavior of our proposed method. We
compared our approach to that of ordinary nonnegative
matrix factorization (NNMF) [46] as well as standard
principal components analysis (PCA), which forms the
fundamental basis of many existing reference-free algo-
rithms (SVA [45], ISVA [32], RUV [21], RefFreeEWAS
[27], ReFACTor [47]). By statistical criteria alone, PCA
slightly outperformed both NNMF and our method, an
anticipated result given that PCA solutions entail no
constraints. However, our method provided mixing co-
efficients that were more interpretable biologically, as
judged by the entropy of the mixing matrix that relates
true cell proportions to their estimates. This improve-
ment arises principally from the fact that PCA constrains
constituent types to be orthogonal and typically produces
z-scores as proxies for cell types, while our proposed
method entails the precise constraints that arise naturally
from the cell mixture problem. In addition, we demon-
strated that our proposed method for estimating K
compared favorably against several alternatives. We also
demonstrated the difficulty of any unsupervised approach
in estimating biologically interpretable cell types when
the variation within the data set provides little informa-
tion about those types: in particular, when the data do not
support a distinction in cell type, the estimated number
of classes may be smaller than the true number, and there
may be consequent collapsing of categories. Finally, we
present evidence that estimation of K is sensitive to
the existence of cellular subtypes (e.g. immune activa-
tion states), and will tend to increase when there is
substantial variation in distinct states of specific cell
types. This phenomenon is consistent with the large
value of K estimated for BL-ra (≥ 10 from Fig. 2b)
and for the tumor data sets, as the histopathology of
rheumatoid arthritis entails profound alterations in
specific leukocytes [48, 49], while it is increasingly be-
ing recognized that cancer cells typically display ex-
treme molecular heterogeneity [50].
Discussion
We have proposed a simple method for reference-free
deconvolution that provides both interpretable outputs,
i.e. proportions of putative cell types defined by their
underlying methylomes, as well as a method for evaluat-
ing the extent to which the underlying reflect specific
types of cells. We have demonstrated these methods in a
wide array of methylation datasets in various tissues and
focused on differing exposures or outcomes.
Overall our deconvolution approach is similar to
many others that have been proposed [29–33]. In par-
ticular, it is very similar to a recent publication that
applied a convex-mixtures approach to deconvolve
RNA expression [33]. Our approach differs from this
one in that it deconvolves DNA methylation, with a
corresponding constraint on the values of M. Our ap-
proach also differs from widely used PCA-based
methods such as SVA in imposing biologically based
constraints, thus resulting in mixture coefficients hav-
ing greater biological interpretation and placing
greater emphasis on coordinated cellular processes. In
addition, importantly, we have provided a more com-
prehensive approach for interpreting the resulting col-
umns of M, unlike most existing methods.
We have provided a novel approach for estimating the
number K^ of cell types, which we have shown to reflect
the level of cellular heterogeneity anticipated from each
tissue we analyzed. More heterogeneous tissues (blood,
breast, and gastric tissues) resulted in higher values of K^ ,
while the more homogeneous tissues had lower values:
K^ ¼ 1 for the (admittedly small) isolated lymphatic and
blood vessel endothelium data sets, while K^ ¼ 2 for
sperm and umbilical cord endothelial tissues. Note,
however, that Fig. 2b reflects ambiguity in the choice of
K^ for sperm and equally supports the choice K^ ¼ 1 ;
similar plots shown in Fig. 2b unambiguously suggest
K^ > 1 for two blood data sets and for an artery data
set. A similar plot for UV-as (not shown) displayed an
unambiguous preference for the choice of K^ ¼ 2 , but
the two putative types of cells did not associate with
any metadata (Table 2). Taken together, these results
demonstrate that our algorithm returns reasonably reli-
able values of K^ reflecting cellular heterogeneity.
Cell mixture proportions Ω were typically significantly
associated with major phenotypes of interest, with the
notable exception of sperm, umbilical vein endothelium,
and placental artery (the former two assumed to be
homogenous tissues). Thus, the radically dimension-
Houseman et al. BMC Bioinformatics  (2016) 17:259 Page 10 of 15
reduced DNA methylation data in Ω can still retain
strongly significant associations with major phenotypes
of interest. However, for other covariates, especially
demographic confounders, there was considerable vari-
ation in significance, demonstrating that Ω can also
show null associations with some covariates. Taken to-
gether, the results show that Ω can distinguish signal
from noise. As the limma analysis demonstrated, re-
sidual signal can still exist in Y even after adjusting for
Ω, although often in a more diminished capacity. In a
few rare cases, the signal increased after adjusting for
Ω. Taken together, these results suggest that a subs-
tantial proportion of the association between Y and
phenotypic metadata X can be factored through the
decomposition Y =MΩT, occasionally clarifying the re-
sidual signal, but more often diminishing it. This find-
ing is significant, as it would strongly suggest that the
results of the vast majority of EWAS studies are driven
by physiologic changes of the underlying composition
of cells within the samples obtained. This is nicely
highlighted by a recent report identifying a specific cell
type driving the associations between smoking and
changes in DNA methylation in peripheral blood [23].
This is in contrast to the prevailing current inter-
pretation of most findings, which has aligned more
strongly with the concept of metastable epialleles.
These alleles represent loci where environmental con-
ditions during development dictate ‘setpoints’ for the
levels of methylation at particular gene sequences that
are consistent across tissues within any person, also
yielding differences in concordant gene expression
[51–54]. The methods described in our work may have
some utility for future discovery of these alleles in that
within-person, cross-tissue comparisons of methyla-
tion profiles would be expected to be enriched for
metastable alleles when the loci that are reflective of
subsets of cell types are described and removed from
comparisons.
On the other hand, we demonstrated that columns of
M correlate with external biological annotation data in a
manner concordant with their interpretation as methy-
lomes specific to constituent cell types. Blood DMP sta-
tus showed the highest associations in blood data sets,
although also somewhat high associations in L[np] and
AR[np], data sets having tissues with potentially inflam-
matory components to pathology. Data sets with tumors
(BR-tcga[t], br-1[t], br-2[t], br-3[t], g[nt], and g[t]) dem-
onstrated high associations with PcG Loci, reflecting the
mitotic activity of tumors; that normal gastric tissue,
g[n] also showed a high association with PcG Loci is con-
sistent with the high level of cellular turnover in gastric
tissues. The Bilenky DMRs showed the strongest associ-
ations for breast tissues, consistent with the fact that the
Bilenky DMRs were obtained from breast tissue, but also
demonstrated strong associations for liver pathologies,
and in arterial tissues AR[n] and AR[np]. Breast and ar-
terial tissues have a mix of epithelial and smooth muscle
tissues, which may explain the arterial results. The asso-
ciation in L[np] may reflect the fibrous character of
pathological liver tissue. REMC DMRs demonstrated
only weak correlation or strong negative correlation with
all tissues, perhaps reflecting the embryonic/develop-
mental nature of the REMC DMRs.
Comparisons with DMPs constructed from Roadmap
WGBS data also demonstrated that the columns of M
reflect epigenetic content concordant with anatomical
expectations; in particular, blood datasets displayed asso-
ciations with DMPs distinguishing CD34+ hematopoietic
stem cells vs. thymus or spleen, as were datasets L[np]
and AR[np], which both included tissue pathologies in-
volving inflammation and immune response. Arterial
data sets displayed associations with DMPs distinguish-
ing smooth muscle from endothelium. Associations with
Roadmap-based DMPs were typically weak for homoge-
neous tissues, in particular sperm. Interestingly, the nor-
mal liver tissue data set L[n] had mostly weak negative
associations; one possible explanation is that the primary
tissues available from the Roadmap were too dissimilar
from normal liver tissue to distinguish subtle anatomical
features. Using the Roadmap data as a pseudo-reference,
normal and pathological tissues were revealed to differ
anatomically along anticipated lines, specifically in that
pathological tissues had greater cellular content reflective
of immune or inflammation processes, and lesser gastro-
intestinal content (gastric and liver tissue) or muscular
content (arterial tissue). Taken together, these results
suggest that the columns of M reflect methylomes of
constituent cell types.
We remark that the unsupervised deconvolution or
approach we have proposed cannot be guaranteed to
recover the methylomes of all constituent cell types;
instead, it recovers the major axes of cellular variation.
This was evident in the comparison of reference-based
and reference-free deconvolution of blood datasets BL-
ra and BL-as; for these datasets, the reference-free ap-
proach recovered the linear combination of reference
methylomes most relevant to characterizing the un-
derlying variation. However, when “re-mixed” back to
proportions of known cell types using a reference
methylome, associations with phenotypic metadata were
consistent with those obtained from reference-based
deconvolution. Functional implications were also typic-
ally similar; for example, supervised and unsupervised
approaches identified several processes involving helper
T-cells and T-cell polarization, consistent with known
Th1/Th2 differentiation processes [49, 55] and T-Cell
polarization processes [48, 56] involved in the etiology
of rheumatoid arthritis. While on its surface this
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suggests that the reference-free approach has no value
when a reference methylome is known (as is the case
with blood), further analysis of the residual information
in the unsupervised deconvolution demonstrated that
reference-free deconvolution may occasionally reveal
distinctions in cell type relevant to characterizing the
underlying variation in the dataset but more subtle than
the potential distinctions fixed in advance by the refer-
ence set; this was evident in the BL-as analysis, for
which the unsupervised approach identified Regulators
of T-Cell Activation and T-Cell Proliferation as signifi-
cant processes potentially altered by arsenic exposure in
Bangladesh. In fact, the impact of arsenic exposure on
regulation of T-cells has been noted [57], and even ob-
served in another study conducted in Bangladesh [58].
Thus, the reference-free approach may provide impor-
tant information that complements a reference-based
approach.
We remark that the failure to retrieve the exact
biologically relevant types is a feature common to all
unsupervised methods, which (as we demonstrate by
simulation) can differentiate heterogeneity only along
the major axes of variation within a data set. Compari-
sons with other existing approaches, both in data ana-
lysis as well as simulations, suggest that our proposed
method produces results that are similar with other un-
supervised methods in their ultimate functional conclu-
sions. However, most existing methods for deconvolving
DNA methylation data rely on adaptations of PCA, thus
producing orthogonal surrogates of cellular function
having no clear cell-type interpretation. Additionally, we
provide some evidence that PCA-based approaches may
require larger degrees-of-freedom to capture the func-
tional relevance of phenotypic associations (conceived as
coordinated cellular processes rather than disparate un-
related effects), although our results are by no means
conclusive. However, an attractive feature of our pro-
posed method is a likelihood-based method of estima-
ting the underlying dimensionality of the cell mixture
component, motivated by biological constraints instead
of an ad-hoc PCA-based model.
As a general point, we have demonstrated the links
suggested in Fig. 1; thus, we have shown that it is pos-
sible to use a reference-free approach to characterize the
extent to which phenotypic associations with DNA
methylation data are explained by differences in con-
stituent cell types. We remark that such distinctions
may be subtle, such as variation in smooth muscle con-
tent or the presence of leukocytes with specialized im-
munological states. There may still exist associations
residual to those with variations in putative underlying
cell types, although they will often be diminished after
adjusting for cell type in the manner we have proposed.
Other reference-free approaches can also distinguish
between associations driven by variation in cell type and
those that are more focal to individual CpG sites, but
our proposed method is based on a biologically based
model that emphasizes the coordination of cellular pro-
cesses, and leads naturally to a bootstrap-based method
for estimating K. Additionally, we have proposed a
method for interpreting the cell-mixture component of
variation in DNA methylation data sets using the esti-
mated methylome matrix, which presumably reflects
coordinated biological activity. While similar insights
may be obtained simply by examining the CpG-specific
associations, we note that there is ongoing controversy
on what “adjustment for cell-type” means in the context
of EWAS analysis. We have previously argued that all
epigenetic variation is ultimately mediated by cell-type,
if the meaning of “cell-type” is conceived of broadly
enough [20]; a more useful framing of the question is
how to identify types of cells that are relevant to the
biological variation being studied. Our proposed ap-
proach helps in partitioning the underlying variation
into units that resemble cell-specific methylomes, so
that these methylomes or the overt functional charac-
teristics of these cells may be further analyzed using
additional biological characterization data. Thus, our
approach emphasizes the extent to which biological
processes are coordinated at the cellular level.
We remark on a few current limitations of our ap-
proach. One is that we have used a crude gene-set pro-
cedure based on variance, which removes “signed”
information and thus precludes the use of algorithms
based on expression signature, such as CTen [59]. An-
other related limitation is a lack of relevant annotation
data. Further work is necessary to adapt the method we
have proposed here to “signed” comparisons, thus enab-
ling a wider array of annotation tools, and to develop
other relevant annotation datasets relevant to identifying
subtle cell types.
Conclusions
We have proposed a simple method for reference-free
deconvolution that provides both interpretable outputs,
i.e. proportions of putative cell types defined by their
underlying methylomes, as well as a method for evalua-
ting the extent to which the underlying reflect specific
types of cells. We have demonstrated these methods in
a wide array of methylation datasets in various tissues
and focused on differing exposures or outcomes. Our
methodology permits an explicit quantitation of the
mediation of phenotypic associations with DNA methy-
lation by cell composition effects. Although more work
is needed to investigate functional information related
to estimated methylomes, our proposed method provides
a novel and useful foundation for conducting DNA
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methylation studies on heterogeneous tissues lacking
reference data.
Methods
Matrix factorization with convex constraints
To obtain a biologically meaningful deconvolution, we
assume an m × n matrix Y representing methylation data
collected for n subjects or specimens, each measured on
an array of m CpG loci, and that the measured values
are constrained to the unit interval [0, 1]. We assume
the following decomposition: Y =MΩT, where M is a
unknown m × K matrix representing m CpG-specific
methylation states for each of K cell types (with row vec-
tors representing profiles each individual CpG) and Ω is
an unknown n × K matrix representing subject-specific
cell-type distributions (each row representing the cell-
type proportions for a given subject, i.e. the entries of Ω
lie within [0, 1] and the rows of Ω sum to values less
than one). Additional file 1: Section S1 describes estima-
tion details, which involve alternating the estimation of
Ω and of M using applications of quadratic program-
ming [60]. Additional file 1: Section S2 describes a
method of estimating K by generating bootstrap sam-
ples, obtaining their deconvolution for each assumed
value of K, and assessing their fit on the samples left out
of the bootstrap.
Empirical examination of proposed methods
We removed chromosome Y data from all datasets; and
we also removed chromosome X data from all but the
breast datasets. For the 450K data sets downloaded from
TCGA, and for the 450K data collected to investigate as-
sociations with arsenic exposure in Bangladeshi neonates
[3, 9], we used the FunNorm algorithm (Bioconductor
package minfi) to process the raw idat files; we obtained
all other data sets as processed average beta values from
Gene Expression Omnibus (GEO). For 450K data sets,
we excluded CpGs with cross-hybridizing probes or
probes with SNPs [61], and used the BMIQ algorithm
[62] (Bioconductor package wateRmelon) to align the
scales of Type I and Type II probes. Finally, for each
data set, we excluded CpGs having missing measure-
ments for over half the specimens.
Associations with phenotypic metadata
As described in Additional file 1: Section S4, permuta-
tion tests were used to assess omnibus significance of
covariates X with fitted cell proportions Ω. As described
in Additional file 1: Section S5, we further compared as-
sociations of Y with X before and after including terms
from Ω in the regression model for Y, using the limma
procedure [63] (via the R package limma) to compute
regression coefficients, using the R package qvalue to
estimate both q-values and the overall proportion π0 of
null associations.
Interpretation of putative cell types
We obtained a list of DMPs for differentiating distinct
major types of leukocytes (Blood DMPs) from the Reinius
reference set [25], and constructed a set of CpGs mapped
to genes considered Polycomb Group proteins (PcG loci),
compiled from four references [64–67] as in our previous
articles [20, 27]. We also constructed a set of CpGs based
on differentially methylated regions (DMRs) obtained
from WGBS data collected by the Epigenomics Roadmap
Project. Additional file 1: Section S6 describes the details
of the construction of these DMP sets. In addition, we
developed a novel approach based on WGBS data from
the Roadmap Epigenomics Project for 24 primary tissues,
described in detail in Additional file 1: Section S7. WGBS
data were aligned with 450K data using the new methy-
Liftover software.
Additional analyses on 450K blood datasets
To compare reference-based analysis with our proposed
approach, we analyzed the two 450K blood data sets,
BL-ra and BL-as, estimating for each data set two sets of
cell-type proportion matrices (K = 7): Ω0 (reference-based)
and Ω1 (reference-free). Details appear in Additional file
1: Section S8. Briefly, to obtain the mixing matrix Ψ
that relates matrices M0 and M1, we used a constrained
projection similar to that used to obtain the reference-
based cell proportion matrix Ω0, and compared M1
with M1 −M0Ψ
T by identifying CpGs with high vari-
ation across their constituent methylomes. In addition,
we compared these highly varying CpGs with with im-
mune activation and immune regulation pathways com-
piled from six sources [68–74].
Additional analyses on datasets with normal and
pathological tissue
We projected Infinium data from each of the three data-
sets sets g[nt], AR[np], and L[np] onto the profile matrix
M obtained by decomposing the Roadmap WGBS data
(Y =MΩT); we then averaged the resulting specimen-
specific cell proportions Ω over tissue status (normal
gastric tissue vs. gastric tumor, normal aorta vs. athero-
sclerotic aorta and atherosclerotic carotid, and normal
liver vs. alcohol-related cirrhotic liver and cirrhotic liver
due to viral infection). Details and results appear in
Additional file 1: Section S9.
Simulations
We based our simulations on estimates obtained from the
BL-ra data set. A Dirichlet distribution was used to model
reference-based estimates of cell composition from the
BL-ra data set, and was also used to generate “true” values
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of cell proportion. Additional microarray error was incor-
porated using beta distributions. We used various mea-
sures of statistical fit and coefficient interpretability to
compare our method with PCA and NNMF, and compared
our proposed method of estimating K with a previously
proposed method based on random matrix theory [32], as
well as an ad-hoc procedure commonly used in factor ana-
lysis. Details appear in Additional file 1: Section S10.
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